Alcon wins FDA approval for AcrySof IQ Toric intraocular lens

According to the company, the new lens offers an enhanced aspheric optic that improves image quality and increases contrast sensitivity in cataract surgery patients with astigmatism. The lens design offers these patients the best opportunity for quality distance vision without glasses.

Alcon will commercially launch the new AcrySof IQ Toric intraocular lens (IOL) shortly.

Bill Barton, president of US operations at Alcon, said: “The AcrySof IQ Toric IOL is yet another intraocular lens technology innovation, that is part of Alcon’s product development strategy to provide cataract surgeons with tools for customized treatment based on individual patient needs.”